Françoise Cailler
Co-founder
Executive Team
surgimab
Austria
Biography
Engineer and Ph.D. of formation, Françoise initially specialized in cellular biology before moving further towards drug development and then entrepreneurship. With over 15 years experience in the development of targeted molecules and therapeutic antibodies in oncology, she transformed SurgiMAb from an academic project to a developing company with more than €10 million raised from creation. She led SurgiMab’s pipe-line from the initial Fluorescence Guided Surgery concept to successful clinical implementation and set up successful clinical partnerships with KOLs over the world. In 2011 Françoise participated to the sales of Bioréalités, a French biotech specialized in the development of therapeutic antibodies in oncology, to Servier just before creating SurgiMab, where she is now CEO and CSO.
Research Interest
Cellular biology and Therapeutics
